Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
How has the iron deficiency anemia treatment market size changed in recent years, and what is the outlook ahead?
The iron deficiency anemia treatment market size has grown rapidly in recent years. It will grow from $7.85 billion in 2024 to $8.89 billion in 2025 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to increasing awareness programs and schemes, a growing baby boomer population, rising nutritional deficits, increasing cases of anemia globally, rising number of women of reproductive age.
The iron deficiency anemia treatment market size is expected to see rapid growth in the next few years. It will grow to $14.54 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to an increase in research and development investments, rising risk in pregnancy, rising nutritional deficits, increasing healthcare awareness, and prevalence of iron deficiency anemia. Major trends in the forecast period include wearable hemoglobin monitors, patient chatbots, iron absorption enhancers, remote monitoring platforms, and neurocognitive monitoring.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24266&type=smp
What are the top economic and technological drivers pushing iron deficiency anemia treatment market growth?
An increase in chronic kidney disease is expected to propel the growth of the iron deficiency anemia treatment market going forward. Chronic kidney disease (CKD) refers to the gradual loss of kidney function over time. The increase in chronic kidney disease (CKD) can be due to rising rates of diabetes, as prolonged high blood sugar levels damage the kidneys’ blood vessels, impairing their ability to filter waste. Iron deficiency anemia treatment helps chronic kidney disease (CKD) to improve oxygen delivery to tissues, reduce fatigue, and enhance quality of life and can potentially improve kidney function by addressing the anemia that often results from reduced erythropoietin production in CKD. For instance, in April 2024, according to the report published by AstraZeneca, a UK-based pharmaceutical company, it is projected that by 2032, up to 16.5% of the population across eight countries, including the United States, Brazil, the United Kingdom, Spain, Germany, the Netherlands, China, and Australia, will be affected by chronic kidney disease (CKD), with a significant increase of up to 59.3% in advanced-stage cases. Therefore, an increase in chronic kidney disease is driving growth in the iron deficiency anemia treatment market.
How is the iron deficiency anemia treatment market segmented by product, application, and end-user?
The iron deficiency anemia treatment market covered in this report is segmented –
1) By Treatment Type: Medications, Blood Transfusions, Other Treatment Types
2) By Drug Type: Ferrous Sulfate, Iron Carbohydrates, Other Drug Types
3) By Therapy Areas: Inflammatory Bowel Disease, Oncology, Other Therapy Areas
4) By Route Of Administration: Oral, Injectable
5) By End User: Hospitals, Clinics, Home Care Settings, Pharmacies
Subsegments:
1) By Medications: Oral Iron Supplements, Intravenous Iron Therapy, Iron-Based Injections, Erythropoiesis-Stimulating Agents
2) By Blood Transfusions: Packed Red Blood Cells Transfusion, Whole Blood Transfusion
3) By Other Treatment Types: Dietary Modifications, Iron Infusion Therapy, Bone Marrow Stimulation
View The Full Market Report:
What evolving trends are creating new opportunities in the iron deficiency anemia treatment market?
Major companies operating in the iron deficiency anemia treatment market are focusing on developing next-generation solutions, such as iron injections, to enhance treatment efficacy, safety, and patient convenience. Iron injection refers to a new or significantly improved injectable iron therapy that represents a major advancement in the treatment of iron deficiency or iron deficiency anemia. For instance, in March 2024, Cadila Pharmaceuticals, an India-based pharmaceutical company, launched Redshot FCM, an intravenous iron therapy using ferric carboxymaltose to treat iron deficiency anemia (IDA). It offers unique features, including advanced ferric carboxymaltose formulation for rapid iron replenishment, minimal anaphylaxis risk, high-dose single-infusion administration for swift correction, and pediatric applicability (1+ years) alongside adult use. It accelerates hemoglobin recovery and targets high-risk groups including pregnant women and cancer patients, with superior tolerability.
Which leading companies are dominating the iron deficiency anemia treatment market landscape?
Major companies operating in the iron deficiency anemia treatment market are Sanofi SA, Fresenius SE & Co. KGaA, Amgen Inc., Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Daiichi Sankyo Company Limited, Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories, Pharmascience Inc., American Regent Inc., PharmaNutra S.p.A., Rockwell Medical Inc., Keryx Biopharmaceuticals Inc., Akebia Therapeutics Inc., Pharmacosmos A/S, Pieris Pharmaceuticals Inc., AdvaCare Pharma USA LLC, Apotex Inc., Shield Therapeutics plc.
Which geographic areas are expected to offer the highest growth opportunities in theiron deficiency anemia treatment market?
North America was the largest region in the iron deficiency anemia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iron deficiency anemia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Iron Deficiency Anemia Treatment Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/customise?id=24266&type=smp
Need Customized Data On Iron Deficiency Anemia Treatment Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24266&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
